WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Technology Software Products Wednesday, January 17, 2018 
Add Press Release News | News Feeds Feeds | Email This News Email

Thyroid Cancer Markets Forecasts Report 2018-2028 - Focus on 21 Major Markets with Key Comorbid Conditions / Features Associated With the Disease
Friday, January 12, 2018

DUBLIN, Jan. 12, 2018 /PRNewswire/ --

The "Thyroid Cancer Forecast in 21 Major Markets 2018-2028" report has been added to's offering.

Thyroid cancer is a cancer originating from follicular or parafollicular thyroid cells. It is a relatively rare cancer, but the most common of the endocrine system. The main clinical split is between differentiated and undifferentiated tumour types, with the majority being well-differentiated.

This report provides the current incident population for thyroid cancer across 21 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Russia, Turkey, Saudi Arabia, South Africa, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. In addition to the current incidence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.

Providing a value-added level of insight, several features of thyroid cancer patients, as well as the main symptoms and comorbidities of the disease have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities of thyroid cancer include:

    --  Familial Adenomatous Polyposis
    --  Acromegaly
    --  Diabetes
    --  Multiple endocrine neoplasia syndromes

    --  Sipple syndrome

Key Topics Covered:

    1. Introduction
    2. Cause of the Disease
    3. Risk Factors & Prevention
    4. Diagnosis of the Disease
    5. Variation by Geography/Ethnicity
    6. Disease Prognosis & Clinical Course
    7. Key Comorbid Conditions / Features Associated With the Disease
    8. Methodology for Quantification of Patient Numbers
    9. Additional Data Available on Request
    10. Top-Line Incidence for Thyroid Cancer
    11. Features of Thyroid Cancer Patients
    12. Papillary Thyroid Cancer Patients
    13. Comorbidities of Thyroid Cancer Patients
    14. Abbreviations Used in the Report
    15. Other Services & Solutions
    16. Reports & Publications
    17. Online Epidemiology Databases
    18. Online Pharmaceutical Pricing Database
    19. References

    20. Appendix

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets

Email This News Email | Submit To Slashdot Slashdot | Submit To Digg | Submit To | News Feeds Feeds

Nav CES 2018 II Cision Roundup | Jan 17, 2018
Nav Synopsys Publishes CISO Report; Identifies Four Distinct Approaches to the CISO Role | Jan 17, 2018
Nav Snowflake Expands its Most Successful Live Cloud Analytics Event to Three Continents | Jan 17, 2018
Nav Thycotic Launches New Privilege Account Management Software Empowering DevOps and Security Teams to Improve IT Security, and Least Privilege Solution to Protect Endpoints Without Impacting Productivity | Jan 17, 2018
Nav Wombat Security Pinpoints Phishing Impacts and Key Regional, Industry, and Generational Differences in Fourth Annual State of the Phish(TM) Report | Jan 17, 2018
Nav Pareteum Awarded $3 Million Contract to Add Mobility to Established South American Data Network Provider | Jan 17, 2018
Nav Actifio Announces Sky 8.0 OnVault for VMware Cloud on AWS | Jan 17, 2018
Nav The low-code development platform market size is expected to grow from USD 4.32 billion in 2017 to USD 27.23 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 44.49% | Jan 17, 2018
Nav konectar KOL Management Platform - Next Generation Cloud Application for Medical Thought Leader Management | Jan 17, 2018
Nav Mobolize Strengthens Solutions Engineering with the Appointment of Ira Stern | Jan 17, 2018

Submit News | View More News View More News